KIDS: OrthoPediatrics Corp. Growth-Adjusted Market Cap to Net Income
The monopoly position of OrthoPediatrics Corp. (KIDS) in the pediatric implant niche ensures stable demand, as confirmed by the PEG ratio on the GURU.Markets chart, where the current parameter equals 0.00. Price stability is based on surgeons' high level of trust in system safety, while the environmental profile relies on standard metal recycling and the energy efficiency of production facilities.
OrthoPediatrics Corp. (KIDS) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio OrthoPediatrics Corp.|KIDS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital orthopediatrics.com|KIDS - Company Debts|Debt to Book Value OrthoPediatrics Inc.|KIDS - Company Long-Term Debts|Short-Term Debt OrthoPediatrics|Immediate Liquidity Ratio orthopediatrics.com
- earnings and valuation multiples indicators:
KIDS - Net Profit|Company Profit Forecast OrthoPediatrics Corp.|KIDS - P/E Multiple|Projected Price to Earnings orthopediatrics.com|KIDS - PEG Multiple|EV/EBITDA Multiple OrthoPediatrics Inc.|KIDS - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months OrthoPediatrics|KIDS - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months orthopediatrics.com|KIDS - Earnings growth in current year|Expected net earnings per share growth next year OrthoPediatrics Corp.
Fundamental company analysis:KIDS (OrthoPediatrics Corp)
The specific nature of precision pediatric implant deliveries for OrthoPediatrics Corp. (KIDS) requires high operational efficiency, which directly impacts profit dynamics and the tracking of the PEG ratio. This coefficient correlates the P/E multiple with earnings growth rates: a value below one signals that the asset is undervalued relative to its expansion, turning the indicator into a tool for identifying undervalued "rockets" with high potential.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple treace.com TMCI|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight Corp) - Price/Earnings to Growth Multiple|ClearPoint Neuro - Growth-Adjusted Payback Ratio|STXS (Stereotaxis, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate neurostar.com STIM|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate invobioscience.com (IVF)|Price/Earnings to Growth Ratio Bone Biologics Corp|AXNX: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple BIOL (Biolase, Inc.)|Company Value to Earnings Growth Ratio DYNT|PEG Multiple FNA (Paragon 28)|Growth-Adjusted Payback Ratio INVO
